To further investigate the molecular basis underlying the dysregulation of B cell homeostasis associated with bovine leukemia virus disease progression in cattle, bovine bax was cDNA cloned and sequenced. The predicted amino acid sequence of bovine Bax revealed a 192-amino-acid protein having extensive identity with the human (97%), murine (93%), and rat (94%) homologues. Because the ratio of Bcl-2 to Bax is believed to predetermine the susceptibility to a given apoptotic stimulus, the relative expression of the genes encoding these oncoproteins was evaluated in cattle naturally infected with BLV. In BLV-infected cattle an increase in the ratios of bcl-2/bax mRNA and protein expression correlated with advancing stages of disease. These findings suggest that in addition to the maintenance of BLV-associated hematopoietic malignancies, the reciprocal expression of Bcl-2/Bax may modulate the induction of B cell expansion typical of BLV disease progression.
INTRODUCTION
Bovine leukemia virus (BLV) is a B-lymphocytotropic retrovirus closely related by genomic organization and disease progression to human T cell leukemia virus type-1 (HTLV-1) (reviewed by Franchini, 1995; Kettmann et al., 1994) . Infection by BLV is characterized by a long clinical latency and a persistent immune response associated with low level or transient viral expression (Haas et al., 1992; Jensen et al., 1991) . Approximately 65% of infected cattle remain clinically and hematologically normal with B cells harboring provirus accounting for 0 to 18% of the peripheral blood mononuclear cells (PBMC) (Mirsky et al., 1996) . In ϳ30% of BLV-infected cattle, a persistent nonneoplastic accumulation of B lymphocytes (persistent lymphocytosis [PL] ), representing 46 to 65% of the total PBMC population, occurs without a concomitant increase in the absolute number of uninfected B cells (Mirsky et al., 1996) . In less than 5% of infections, a fatal, monoclonal, neoplastic transformation of B lymphocytes appears, resulting in lymphocytic leukemia (LL) or malignant lymphoma (ML). In cattle with LL, the PBMC consist almost exclusively of BLV-infected neoplastic B cells, whereas cattle with ML typically exhibit normal hematological profiles despite having solid tumors comprised of BLV-infected B lymphocytes. Because the risk of developing LL/ML is greater in cattle with PL than in BLV-seropositive cattle with normal hematological parameters, PL may represent a preneoplastic condition (Ferrer et al., 1979; Kettmann et al., 1980) . Similar to the etiopathogenesis of HTLV-1 in humans, the development of BLV-associated hematopoietic malignancies represents a violation in cellular homeostasis. The maintenance of cellular homeostasis reflects a balance between cell proliferation and cell death. Increased proliferation or prolonged survival of infected cells may explain the dysregulation of B cell homeostasis associated with BLV disease progression. However, in vitro studies in our laboratory have shown that the progressive B cell expansion associated with BLV infection represents a suppression of programmed cell death (apoptosis) and increased expression of the bcl-2 protooncogene (manuscript submitted). Although Bcl-2 is known to promote cell survival (reviewed by Yang and Korsmeyer, 1996) the mechanism by which this protein and its homologs control the apoptotic pathway remains unknown. Bax, a conserved homologue to Bcl-2, counters the death repressor activity of Bcl-2 and can accelerate apoptosis (Oltvai et al., 1993) . Recent studies suggest that the relative ratios of Bcl-2 to Bax, rather than the singular expression of either protein, can prescribe survival or death to diverse apoptotic stimuli (Oltvai and Korsmeyer, 1994; Thomas et al., 1996) .
Because BLV infection in cattle represents an established model for the study of analogous human retroviral associated diseases, this system is ideal to investigate the interplay between viral infection and the modulation of effectors of apoptosis in the development of hemato- poietic malignancies. In this study, we have identified, cDNA cloned, and sequenced the bovine homologue of the bax protooncogene. Furthermore, we extend our previous findings by demonstrating a progressive increase in the ratio of bcl-2/bax expression associated with B cell accumulation and leukemogenesis in BLV-infected cattle.
RESULTS

Cloning and characterization of bovine bax␣
Northern blot analysis was used to determine the major bax species present within the calf thymus RNA utilized to synthesize the bovine cDNA library. A riboprobe complementary to amino acids 25 to 118 (spanning exons 3 and 4) of human bax detected an intense 1.0-kb and a minor 1.5-kb transcript (Fig. 1) . These transcripts correspond in size to those encoding the membrane-associated ␣ and cytosolic ␤ isoform of bax, respectively (Oltvai et al., 1993) . A single 1.0-kb transcript was detected in control cell line 729 RNA.
Characterization of the original bovine cDNA library revealed an approximate frequency of clones containing the bax coding domain of 1 per 8 ϫ 10 6 . Enzymatic enrichment increased this frequency to 1 per 500, allowing the independent isolation of two cDNA clones encoding the entire bovine bax␣ major open reading frame (ORF). DNA sequence analysis of these clones revealed a 576-bp ORF flanked by 49-bp of 5Ј and 217-bp of 3Ј noncoding sequence (Fig. 2) . The methionine initiation codon for this cDNA occurs in a strong context, conforming to a Kozak consensus motif (Kozak, 1996) which is identical to the translational initiation sequence for human bax (Oltvai et al., 1993) . Based on the neighborjoining method for reconstructing phylogenetic trees (Saituo and Nei, 1987) , the bovine bax␣ ORF displayed 95, 89, and 90% identity with the human, murine (Oltvai et al., 1993) , and rat (Tilly et al., 1995) homologues, respectively. Similarly, the predicted amino acid sequence of bovine Bax␣ revealed 97, 93, and 94% respective identity with the human, murine, and rat proteins.
Reciprocal expression of bax and bcl-2 correlates with disease progression in BLV-infected cattle C-RT-PCR was used to evaluate the relative expression of bax and bcl-2 mRNA in cattle in various stages of BLV infection. The oligonucleotide primer sets used in this assay were positioned to detect the ␣ integral membrane forms as well as the cytosolic ␤ species of bax and bcl-2. Figure 3A illustrates the specificity of the C-RT-PCR protocol for the simultaneous detection of bax (␣ ϩ ␤) and bcl-2 (␣ ϩ ␤) mRNA.
This protocol was used to determine the ratio of bcl-2/bax transcriptional activity in 44 cattle (10 BLV Ϫ , 10 BLV ϩ , 10 BLV ϩ /PL, and 14 BLV ϩ /LL/ML). As shown in Fig. 3B , there was a significant, progressive increase in the ratio of bcl-2/bax mRNA with advancing stages of BLV-associated disease. In PBMC isolated from 3 of 10 BLV-infected cattle with the preneoplastic condition of PL, an increase in bcl-2/bax mRNA expression relative to nonneoplastic PBMC was detected. Standard regression analysis showed no correlation between bcl-2/bax mRNA expression and total PBMC counts in cattle with PL (R ϭ 0.248, P ϭ 0.4889). Increased ratios of bcl-2/bax expression were also observed in neoplastic lymphocytes isolated from 10 of 14 cattle with LL or ML relative to PBMC derived from BLV Ϫ , BLV ϩ , or PL cattle. Furthermore, the bcl-2/bax mRNA expression within tumor cells was uniformly greater than in nonneoplastic PBMC derived from the same cattle with ML.
Relative levels of bax and bcl-2 translational activity were examined using Western blot analysis. As shown in Fig. 4A , proteins corresponding in size to Bax␣ (21 kDa) (Oltvai et al., 1993) and Bcl-2␣ (26 kDa) (Tsujimoto and Croce, 1986; Tsujimoto et al., 1987) , respectively, were detected within both neoplastic and nonneoplastic bovine tissues using anti-human gene-specific antibodies. The differential expression of Bax and Bcl-2 between these tissues, which were isolated from a single cow with ML, is representative of the pattern of increased Bcl-2/Bax protein ratios associated with BLV-induced malignancy (Fig. 4B ). Similar antibody specificities were observed from the analysis of human 729 cell line protein lysates; however, human Bax showed a minor decrease in electrophoretic mobility relative to the bovine Bax homologue (data not shown). Additionally, a minor 17- 19-kDa protein analogous to the ␥ isoform of Bax described by Krajewski et al. (1994) was detected in human 729 cell line lysates (data not shown) but was absent in all bovine tissues examined. Analysis of 33 cattle (7 BLV Ϫ , 7 BLV ϩ , 13 BLV ϩ /PL, and 6 BLV ϩ /LL/ML) revealed a pattern of increasing Bcl-2/Bax ratios with advancing stages of BLV-associated disease, similar to that observed for the transcriptional activity of bax and bcl-2 (Fig. 4B) . Moreover, segregation of cattle with PL from hematologically normal cattle was more dramatic based on Bcl-2/Bax protein ratios than measurement of mRNA expression. These differences in ratios of bcl-2/bax mRNA, compared to protein expression, may reflect steps in the transcriptional and translational control of these protooncogenes. Comparable ratios of Bcl-2/Bax were detected in PBMC isolated from BLV Ϫ cattle, from BLV ϩ cattle with normal hematological parameters, and in nonneoplastic PBMC from cattle with ML. Fewer cattle were included in the analysis of Bcl-2/Bax protein ratios than for the evaluation of the relative expression bcl-2/ bax mRNA because of limitations in tissue availability.
DISCUSSION
The mechanisms which control apoptosis have not been completely defined; however, it is evident that this universal process is regulated by a genetic program involving both effectors and repressors (Hale et al., 1996) . Among the regulators of apoptosis, the Bcl-2 protein family is unique by virtue of its action on a distal step in an evolutionary conserved pathway . Many viral proteins have been shown to regulate apoptosis through the modulation of Bcl-2 expression or by encoding proteins with similar functions to this protooncogene. Among the Retroviridae, endogenously expressed Tat and Tax of the human immunodeficiency virus type-1 and HTLV-1, respectively, have been shown to inhibit activation-induced apoptosis through the regulation of Bcl-2 expression (Copeland et al., 1994; McCloskey et al., 1997) . Similarly, we have previously demonstrated increased expression of BLV tax mRNA (Reyes and Cockerell, 1996) as well as bcl-2 mRNA and protein (manuscript submitted) in lymphocytes isolated from BLV-infected cattle with P or LL/ML, compared to hematological normal cattle. Although both Bcl-2 and Bax function to maintain cellular homeostasis, few studies have investigated the role of Bax in virally induced leukemogenesis. A recent report showing in vitro repression of the human bax promoter by HTLV-1 Tax (Brauweiler et al., 1997) suggests that BLV may influence the expression of the Bax protein.
To investigate the potential role of Bax in BLV-induced disease, the bovine homologue of this repressor of programmed cell death was cDNA cloned and sequenced. The predicted amino acid sequence of bovine bax shares strong phylogenetic homology with the human and murine Bax proteins (Oltvai et al., 1993) . Moreover, the hypothetical`suicide domain'' comprising residues 55±77 of Bax (Hunter and Parslow, 1996) is identical between these species. Rueda et al. (1997) recently described a partial cDNA sequence of bovine bax encoding a protein fragment (residues 36±169) with greater divergence from human Bax than the predicted amino acid sequence described in the present study. These discrepant results may reflect sequence anomalies within the partial cDNA which was derived from a single RT-PCR fragment (Rueda et al., 1997) . Cross-reactivity of the antihuman Bax antibody with bovine cellular lysates reinforces our findings of minimal divergence between human and bovine Bax (97% similar) since this antibody fails to recognize the more divergent murine protein (93% similar). Interestingly, the human and bovine bax mRNA transcripts are 98% similar over the 5Ј noncoding seare presented as ratios of bcl-2/bax mRNA. The BLV infection and disease status of each category of cattle are shown below the abscissa. Nonneoplastic PBMC isolated from cattle with ML are designated as ML*. Datum points represent the average results obtained from individual cattle analyzed in triplicate. Heavy horizontal bars represent the mean value of each data set. Letters adjacent to the mean values indicate statistical significance: a, different from BLV Fig. 2 and encode a NotI restriction site located 49 bp proximal to the methionine initiation codon. Since this enzyme was used to construct the calf thymus cDNA library, the bovine bax cDNA clones described in the present study do not contain the theoretical transcription start site which has been mapped to position Ϫ372 in the human gene (Miyashita and Reed, 1995a) .
It has been established that both Bax and Bcl-2 play important roles in the apoptotic pathway and that relative, rather than absolute, levels of these proteins determine the susceptibility to a given apoptotic stimulus (Oltvai and Korsmeyer, 1994) . Our data demonstrating an increase in the ratios of bcl-2/bax mRNA and protein in neoplastic lymphocytes from BLV-infected cattle are similar to findings in humans with B cell chronic lymphocytic leukemia (Pepper et al., 1996) . The wide distribution of bcl-2/bax mRNA and protein expression in lymphocytes derived from BLV-infected cattle with LL/ML or humans with B cell chronic lymphocytic leukemia may reflect progression through the hypothetical model of molecular cell death checkpoints proposed by Oltvai and Korsmeyer (1994) . This suggestion is supported by our finding of increased bcl-2/bax mRNA and protein in PBMC from cattle with the preneoplastic condition of PL. These results argue that in addition to the maintenance of BLVassociated hematopoietic malignancies, the reciprocal expression of Bax/Bcl-2 may modulate the induction of B cell expansion typical of BLV disease progression.
In this study, we evaluated the relative expression of bax and bcl-2 in nonneoplastic, preneoplastic, and neoplastic tissues, containing unequal populations of B and T cells. Our results show increased expression of bcl-2, relative to bax, in preneoplastic PBMC from cattle with PL and neoplastic lymphocytes from cattle with LL or ML. As a result of infection with BLV, these tissues are biologically enriched in B cells. Interestingly, immunoblot analysis of normal human PBMC have demonstrated relatively high levels of Bax protein in B cells, compared to T cells, whereas expression of Bcl-2 was high in both cell phenotypes (Ohta et al., 1995) . Furthermore, multicolor flow cytometric analysis has shown comparable levels of Bcl-2 protein among peripheral B and T lymphocytes (Aiello et al., 1992) . These studies indicate that the relative expression of bcl-2/bax is greater in normal peripheral T than in B cells. Taken together, our findings suggest that differences in the expression of bax and bcl-2 within BLV-infected and noninfected lymphocytes reflect an association between the modulation of these oncoproteins and BLV. Recent reports have shown that bax is a p53 primary response gene (Miyashita and Reed, 1995b) and that transcriptional activation of bax by p53 is associated with a simultaneous decrease in the steady-stage levels of bcl-2 mRNA and protein. Using a transgenic mouse model in which p53-mediated apoptosis attenuates tumor growth, Yin et al. , demonstrated that Bax is required for half of the p53-dependent apoptosis in choroid plexus epithelium (Yin et al., 1997) . Interestingly, HTLV-1 Tax has been shown to suppress the expression of p53 (Uittenbogaard et al., 1995) . Additionally, mutations in p53 have been associated with BLV-induced malignancies in cattle (Dequiedt et al., 1995) . These findings illustrate the complexity of the pathways which regulate cellular homeostasis and their potential vulnerability to viral disruption.
The results of the present study demonstrate the value of cattle naturally infected with BLV and in well-defined stages of disease, as an animal model for analogous retroviral-induced disease in humans and to delineate the interplay between regulators of cellular homeostasis. Furthermore, the bovine bax␣ cDNA and deduced protein sequence reported here provides additional information on conserved residues within the Bcl-2 protein family which should be useful in future studies to delineate their role as mediators of programmed cell death.
MATERIALS AND METHODS
Animals and cell lines
Adult Holstein female cattle from commercial dairies were classified as BLV-seropositive (BLV ϩ ) or -seronegative (BLV Ϫ ) based on the presence or absence of antibodies against BLV gp51 by using an agar gel immunodiffusion assay (Leukassay B; Rhone Merieux, Inc., Athens, GA). Cattle were categorized as having PL if their lymphocyte counts exceeded 9.5 ϫ 10 3 /l on consecutive evaluations at м3-month intervals. Solid tumor tissues were collected from cattle with ML at surgery or immediately following euthanasia and processed by manual disruption (Jensen et al., 1991) to obtain singlecell suspensions. PBMC and single-cell suspensions of tumor tissues were purified by density gradient centrifugation on Ficoll±Hypaque (Histopaque 1077; Sigma Chemical Co., St. Louis, MO). Thymic tissue from a 17-day-old Holstein male calf was used to generate the bovine cDNA library. Following collection, all tissues were either processed immediately or maintained at Ϫ70°C until use. The Epstein±Barr virus-transformed human B lymphoblastoid cell line, 729 (Glassy et al., 1983) , was used as a source of control RNA and protein.
RNA isolation
Total cellular RNA was isolated using TRIzol reagent (Life Technologies, Gaithersburg, MD) and treated with RNase-free DNasel. Polyadenylated RNA was enriched from total cellular RNA using oligo(dT) cellulose as previously described (Celano et al., 1993) .
Cloning of bovine bax
Reverse transcription±PCR (RT-PCR) with oligonucleotides derived from the human bax sequence was used to amplify a 280-bp fragment from calf thymus RNA. Amplification was performed by incubating 0.5 g total RNA with 50 pmol each of primers 5HBAX75 and 3HBAX353 (Table 1) at 75°C for 10 min. The reaction was subsequently cooled at 0°C for 10 min and combined with 1 U of Prime RNase inhibitor (5 Prime 3 3 Prime, Inc., Boulder, CO), 10 mM Tris±HCl (pH 8.3), 50 mM KCl, 1.75 mM MgCl 2 , 0.2 mM deoxyribonucleoside triphosphates (dNTPs), 4 U of Avian myeloblastosis virus reverse transcriptase (Promega, Madison, WI), and 2 U of Taq polymerase (Boehringer Mannheim Corp., Indianapolis, IN), in a total volume of 50 l. The RT-PCR temperature profile consisted of 46°C for 45 min, 95°C for 3 min, 23 cycles of 94°C for 30 s, 69°C (decreasing 1°C each cycle) for 20 s, and 72°C for 20 s, and 17 cycles of 94°C for 30 s, 46°C for 20 s, and 72°C for 20 s. The 280-bp product was cloned into the pCRII vector (Invitrogen, San Diego, CA) and sequenced using the ABI 377 dye terminator sequencing system (Perkin Elmer, Foster City, CA). Based on this newly derived sequence, oligonucleotides were synthesized to enrich and screen a cDNA library for the bovine bax␣ gene.
A bovine cDNA library consisting of 9 ϫ 10 5 primary clones was previously prepared from calf thymus RNA using the SuperScript plasmid cDNA system (Life Tech- (Oltvai et al., 1993) . b Nucleotide position in the bovine bax␣ sequence (see below). c Nucleotide position in the bovine bcl-2 sequence (Submitted for publication).
nologies) (manuscript submitted) and was amplified on solid medium. Following conversion of this library to single-stranded phagemid DNA (Kunkel et al., 1991) , cDNA clones encoding bax were selectively reverted to double-stranded molecules. Single-stranded library cDNA (3g) was combined in a total volume of 100 l with 0.1 M oligonucleotide 3BBAX281 (Table 1) , 20 mM Tris±HCl (pH 8.8), 10 mM KCl, 10 mM (NH 4 ) 2 SO 4 , 2 mM MgSO 4 , 0.1% Triton X-100, 0.2 mM dNTPs, 1 U of Deep Vent DNA polymerase (New England Biolabs Inc., Beverly, MA), and incubated at 94°C for 5 min, 62°C for 1 min, and 68°C for 10 min. The resulting double-stranded, nicked molecules were ligated for 10 min at 62°C with 2 U of Ampligase (Epicenter Technologies, Madison, WI), and the residual single-stranded cDNA molecules removed with mung bean nuclease (New England Biolabs). The bax-enriched cDNA pool was then transformed into Escherichia coli DH12S (Life Technologies) and was screened using oligonucleotides 5HBAX75 and 3HBAX291 (Table 1) together with a dilutional PCR protocol as previously described (Alfandari and Darribere, 1994) . Two clones containing the bovine bax␣ coding domain were isolated and both strands of each clone were sequenced using the ABI 377 dye terminator sequencing system with oligonucleotides 5HBAX75, 5HBAX166, 3HBAX291, and 3HBAX353 (Table 1 ) and the M13 universal sequencing primers (Perkin Elmer). DNA and protein sequence analysis was performed using the Clustal V alignment package (European Molecular Biology Laboratory, Heidelberg, Germany).
At each stage of the cDNA enrichment procedure, the frequency of clones containing the bax coding domain sequence was estimated. Serial dilutions of bacterial clones were grown to saturation and assayed using PCR with oligonucleotides 5HBAX75 and 3HBAX353.
Northern blot analysis
Polyadenylated RNA (4 g/well) was separated on 1.5% agarose±0.66 M formaldehyde gels, transferred to positively charged nylon (Magnacharge; Micron Separations Inc., Westborough, MA) and hybridized with 5 ϫ 10 Ϫ10 M digoxigenin-labeled human bax riboprobe (see below) in rapid hybridization buffer (Amersham, Arlington Heights, IL). The membranes were blocked for 1 h at 37°C in 1% (w/v) Hammarsten casein (Gallard-Schlesenger, Carle Place, NY), 0.05% Tween 20, 150 mM NaCl, 50 mM Tris±HCl (pH 7.8) (blocking buffer), and incubated at 27°C for 1 h with 1 ϫ 10 Ϫ4 U/ml alkaline phosphataseconjugated anti-digoxigenin antibody (Boehringer Mannheim Corp.). Following four serial washes in blocking buffer at 27°C for 15 min, hybridized RNA was visualized using CSPD chemiluminescence substrate (Tropix, Bedford, MA) according to the manufacturer's instructions.
The bax riboprobe was constructed using RT-PCR with oligonucleotide primers 5BBAX72 and 3BBAX412 (Table   1) to amplify a cDNA fragment encoding amino acids 25 to 118 of human bax from cell line 729 RNA. Reaction conditions were as described above except that the following temperature profile was used: 46°C for 45 min, 95°C for 3 min, 35 cycles of 94°C for 30 s, 60°C for 20 s, and 72°C for 20 s. The product was cloned into the pCRII vector (Invitrogen), and antisense RNA was transcribed using the Ampliscribe System T7 (Epicenter Technologies), substituting 2.6 mM digoxigenin-11-UTP (Boehringer Mannheim Corp.) and 4.9 mM unlabeled UTP for the recommended 7.5 mM UTP in the final reaction mixture.
C-RT-PCR
The relative levels of bax and bcl-2 transcriptional activity were evaluated by comparative RT-PCR (C-RT-PCR) using oligonucleotide pairs 5BBAX72-3BBAX281 and BCL54-BCL34 (Table 1) to coamplify bax and bcl-2 mRNA, respectively. Reaction conditions were as described above except that the following temperature profile was used: 46°C for 45 min, 95°C for 3 min, 7 cycles of 94°C for 30 s, 69°C (decreasing 1°C each cycle) for 20 s, 72°C for 20 s, and 29 cycles of 94°C for 30 s, 62°C for 20 s, and 72°C for 20 s. The specificity of bax and bcl-2-amplified products was verified by Southern blot hybridization using alkaline phosphatase-labeled oligonucleotide probes 5HBAX166 and BP (Table 1) , respectively (Reyes and Cockerell, 1993) . The relative ratios of bax and bcl-2 mRNA in each sample were determined by densitometric analysis of ethidium bromide-stained agarose gels using an IS-1000 digital imaging system (Alpha Innotech, San Leandro, CA). In each experiment, negative control reactions consisting of all the C-RT-PCR components except for the target RNA were performed.
Western blot analysis of Bax and Bcl-2
Total cell lysates of PBMC and tumor tissues were prepared as previously described (Tamaru et al., 1993) , diluted in Laemmli's sample buffer (Laemmli, 1970) , and boiled for 2 min. Proteins (20 l, 10 6 cells) were separated by 12% sodium dodecyl sulfate±polyacrylamide gel electrophoresis and transferred to polyvinylidene difluoride membranes. The membranes were blocked for 1 h at 37°C in blocking buffer, followed by incubation for 1 h at 27°C with 0.25 g/ml mouse anti-human Bax (4F11; Medical & Biological Laboratories CO., LTD, Nagoya, Japan) and 0.25 g/ml mouse anti-human Bcl-2 (124; Dako Corp., Carpinteria, CA) antibodies. Following eight serial washes in blocking buffer at 27°C for 15 min, 0.4 ng/ml alkaline phosphatase-conjugated goat anti-mouse IgG (Calbiochem, Cambridge, MA) was added and the membranes were incubated at 27°C for 45 min. Immunoreactive proteins were visualized using CDP-Star chemiluminescence substrate (Tropix) according to the manufacturer's instructions. The relative ratios of Bax and Bcl-2 in each sample were determined by densitometric analysis of the autoradiographs using an IS-1000 digital imaging system.
Statistical analysis
The Kolmogorov-Smirnov test was used to determine normality of the distribution of each data set. Differences in the cellular expression of bcl-2/bax mRNA or protein between categories of cattle were determined using a multifactorial ANOVA followed by the Fisher's least significant difference post hoc test.
